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Abstract
The contribution of the decline in thymic activity for the emergence of autoimmunity is still
debatable. Immune-competent adults submitted to complete thymectomy early in life pro-
vide a unique model to address this question. We applied here strict criteria to identify adults
lacking thymic activity based on sjTREC levels, to exclude thymic rebound and/or ectopic
thymuses. In agreement, they featured severe naïve CD4 T-cell depletion and contraction
of T-cell receptor diversity. Notwithstanding this, there was neither increased incidence of
autoimmune disease in comparison with age-matched controls nor significant changes in
their IgG/IgA/IgM/IgE autoreactivity profiles, as assessed through extensive arrays. We rea-
soned that the observed relative preservation of the regulatory T-cell compartment, includ-
ing maintenance of naïve regulatory CD4 T-cells, may contribute to limit the emergence of
autoimmunity upon thymectomy. Our findings have implications in other clinical settings
with impaired thymic activity, and are particularly relevant to studies of autoimmunity in
ageing.
Introduction
The thymus is essential to the establishment of the “peripheral” T-cell compartment before
birth and during the accelerated somatic growth of childhood, and contributes to its continu-
ous replenishment until at least the sixth decade of life[1]. Thymus removal early in infancy
during corrective cardiac surgery is, therefore, associated with marked contraction of the naïve
T-cell subset, as well as with the presence of markers of premature immune senescence, as a
result of homeostatic naïve T-cell proliferation/differentiation[1, 2]. This is thought to occur
mainly in response to self and environmental antigens[2], raising the question whether early
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thymectomy leads to an increased risk of autoimmunity and/or allergic disease. The few stud-
ies available are not conclusive[3–8]. The discrepant results may be in part due to cohort het-
erogeneity regarding age, length of follow-up post-thymectomy and degree of residual thymic
activity[3–8]. Notably, thymic recovery has been reported in some individuals [9, 10].
Autoimmunity and allergy are controlled by a subset of regulatory CD4 T-cells (Tregs),
defined by FoxP3 expression[11–13]. Tregs generated in the thymus are particularly impli-
cated in the maintenance of self-tolerance, since they are thought to have a more autoreactive
TCR repertoire[14]. They egress from the thymus with a naïve phenotype (naïve-Tregs), and
continuously replenish the fully-suppressor memory-Treg compartment throughout life.
We recently reported that naïve-Tregs are preserved in adults more than 18y (median 21y)
after complete thymectomy early in infancy, despite the marked contraction of conventional
naïve CD4 T-cells[15, 16]. Importantly, in contrast to other studies[3, 4], we specifically
excluded individuals with evidence of remaining thymic activity, based on single-joint T-cell
receptor excision circle (sjTREC) quantification[15, 16]. sjTRECs are by-products of TCR
rearrangements during T-cell development in the thymus that are enriched in recent-thymic
emigrants and progressively lost as cells divide in the periphery[17]. We strictly selected indi-
viduals with circulating levels of sjTREC/μl clearly below the lower level found in healthy sub-
jects, in addition to a surgical report of complete thymus removal[15, 16]. In agreement with
our data, naïve-Treg preservation was also found in a cohort of recently thymectomized chil-
dren[18].
Here we investigated the possibility that the maintenance of naïve-Tregs limits the develop-
ment of autoimmunity and/or allergy likely associated with the skewed conventional T-cell
repertoire upon complete thymectomy[16].
Patients and methods
We compared our cohort of adults with strictly defined complete thymus removal in early
infancy with age-matched healthy individuals (Table 1). Thymectomized individuals were
selected based on severely reduced sjTRECs/μl[15, 16] at the time of our evaluation (July
2011—October 2012).
All subjects gave written informed consent for blood sampling. The study was approved by
the Ethical Boards of Faculdade de Medicina da Universidade de Lisboa, Centro Hospitalar
Lisboa Norte, and Hospital de Santa Cruz, Portugal.
An extensive structured questionnaire was applied to all individuals by the same investiga-
tor to assess clinical manifestations of autoimmunity and allergy, in parallel with the evaluation
of serum reactivity to large panels of autoantigens and allergen components. Modules of
ISAAC Questionnaire validated for Portuguese speaking adults were included in this evalua-
tion[19]. Regarding autoimmunity, we applied an in-house developed detailed clinical ques-
tionnaire collecting the previous diagnosis and the signs/symptoms suggestive of autoimmune
disease.
Ex-vivo phenotypic analysis of lymphocyte subsets was performed in freshly-collected
whole blood by 8-color flow cytometry, as previously described[15, 16].
Autoantigen microarrays were used to detect IgG/IgM or IgA/IgE autoantibodies in serum
to a panel of 125 autoantigens[20]. The same chip was used to test all individuals for each iso-
type. Serum samples were treated with DNAse I (1:50) before incubation with autoantigen
arrays. Autoantibodies were detected in parallel arrays, with Cy3-labelled anti-human IgG and
Cy5-labelled anti-human IgM (Jackson ImmunoResearch, West Grove, PA, USA), or Cy3-la-
beled anti-human IgA (Jackson ImmunoResearch) and TRITC-conjugated anti-human IgE
(ThermoFisher Scientific) for imaging. Fluorescence was quantified using GenePix 4400A
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Fig 1. IgG autoantibody profiles. Heatmap of serum IgG autoantibody reactivity in adults thymectomized
early in infancy (T) and controls (C) clustered by autoantigen and subject group. Reactivity intensity was
normalized and log2-transformed, and 121 autoantibodies meeting minimal net fluorescence intensity
requirements are presented. Key color bar corresponds to quantified reactivity.
https://doi.org/10.1371/journal.pone.0180385.g001
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scanner with appropriate laser wavelengths and generated Tiff images. Genepix Pro 7.0 soft-
ware was used to analyse the image and create the Gene Pix Results (GPR) file. The net fluores-
cence intensities were normalized using purified human IgG/IgM/IgA/gE spotted onto each
array. Data obtained from duplicate spots were averaged. Signal-to-noise ratio (SNR) was used
as a quantitative measure of the ability to resolve true signal from background noise, with
SNR3 considered true signal. Normalized profiles of antigen-microarrays were log2 trans-
formed, and gplots package[21]were used to generate non-supervised hierarchical clustering
heatmaps of the Euclidean distance matrix estimated from serum autoantibody reactivities. R
statistical environment[22] and Limma package[23] were used to test and infer for differential
antigen reactivity.
In order to expose a putative increase in the frequency of IgE sensitizations (sIgE) upon
complete thymectomy, we used ImmunoCAP ISAC1 (TermoFischer scientific), a miniatur-
ized immunoassay platform, to assess serum specific IgE (sIgE) to 112 allergen components
from 51 aeroallergen or food sources. This test was performed in the same day for all individu-
als (Table 1), following the manufacturer´s instructions.
Results
Adults with complete thymectomy early in infancy featured very low naïve CD4 and CD8 T-
cell counts (Table 1), as expected[4, 5, 7, 8, 24–26]. Importantly, their Treg compartment was
preserved, with evidence of similar expression levels of markers associated with suppressive
function phenotype within memory-Tregs, based on FoxP3, CTLA-4 and CD39 expression
levels [27, 28](Table 1).
We found no autoimmune manifestations based on a structured clinical questionnaire. In
order to reveal a possible subclinical increase in IgG, IgM, IgA and/or IgE autoreactivity, we
took advantage of autoantigen array-based technology[29], an emergent approach with high
sensitivity for early and large-scale autoantibody identification[29]. The autoreactivity profiles
of the complete thymectomized adults were compared with age-matched representative con-
trols (Table 1). By fitting a linear model to the normalized data (S1–S4 Tables), using R statisti-
cal environment[22] and Limma package[23], we did not find significant differences in serum
IgG (Fig 1), IgA (Fig 2), IgM (Fig 3), as well as IgE (Fig 4) reactivity between cohorts (P>0.05).
Moreover, the clustering analysis showed a clear inability to correctly assign thymectomized
and controls on the basis of antigen reactivity profiles (Figs 1–4).
In spite of the lack of significant differences after applying the multiple test correction,
when analysing IgG reactivity to distinct autoantigens, we identified 18 autoantibodies with
higher expression within complete thymectomized than in age-matched healthy subjects, (S1
Table; P<0.05, before multiple testing correction). Their targets included nuclear antigens
(Sp100, chromatin, histone H1, ribophosphoprotein P1, SmD2, SmD3, TIF1gamma, Sm),
cytoplasmic/membrane proteins (mitochondrial antigen, tissue transglutaminase, liver cyto-
solic 1 antigen, sphingomyelin), cell matrix proteins (fibronectin), glomeruli-specific proteins
(glomerular basement membrane) and circulating proteins (complement C3a, complement
C4, complement C8, factor D). Interestingly, these autoantigens have been identified in sys-
temic lupus erythematosus (SLE) patients[29], some of them with high specificity, such as
SmD proteins. The SLE studies revealed an association between particular IgG autoantibody
Fig 2. IgA autoantibody profile. Heatmaps of serum IgA autoantibody reactivity in adults thymectomized
early in infancy (T) and controls (C), clustered by autoantigen and subject group. Reactivity intensities were
normalized and log2-transformed; and 121 IgA autoantibodies meeting minimal net fluorescence intensity
requirements are presented. Key color bar corresponds to quantified reactivity.
https://doi.org/10.1371/journal.pone.0180385.g002
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clusters and overall disease activity or lupus nephritis[29], one of which was partially repro-
duced in our complete thymectomized cohort (glomerular basement membrane/chromatin
antibodies). Additionally, a cluster combining IgG autoantibodies to liver cytosolic antigen 1/
mitochondrial antigen/tissue transglutaminase, antigens clearly associated with autoimmune
liver disease[30], was also found in our thymectomized adults.
Recent data recall attention for a role of IgE reactivity against self-peptides in autoimmunity
although their significance is still debatable[31]. We were able to identify IgE reactivity to a rel-
atively small number of antigens in both cohorts (a median of 34 per individual in complete
thymectomized versus 31 in controls in a total of 125 antigens included in the array, P>0.05).
There was no statistical difference between healthy and thymectomized. We also found 4 IgE
autoantibodies, not previously reported[31], for which we observed different levels of reactivity
between thymectomized and control individuals.(heperan sulfate, Factor P, mitochondrial
antigen M2, entaktin EDTA (S4 Table; P<0.05, before multiple testing correction), but in con-
trast to IgG, these differences did not feature a consistent trend between the two cohorts.
These findings reinforce the need for further investigation on IgE autoreactivity[31].
Regarding allergy, we found no significant differences in the prevalence of clinical manifes-
tations in complete thymectomyzed and age-matched control individuals (Table 1). Allergic
rhinitis was the most frequent disease in both cohorts, as expected in young adulthood, and
atopy was documented only in individuals with rhinitis (Table 1). We also performed a micro-
array to 112 allergen components that revealed positive sIgE in patients with allergic disease,
in agreement with their clinical manifestations (Table 1). Our findings suggest that thymec-
tomy in early age has no major impact on the degree of IgE-sensitization against food or air-
borne allergens.
Discussion
Our study, that was strictly designed to include only adults without evidence of thymic activity
upon thymus removal in infancy, revealed no increase of clinical/subclinical manifestations
of allergy or of autoimmune diseases, as compared with a group of age matched healthy in-
dividuals. This occurred despite these individuals featured marked contraction of the con-
ventional naïve T-cell pool and a restricted T cell-receptor diversity[16]. It is likely that the
absence of autoimmune manifestations may be related to the parallel preservation of the Treg
compartment, given the major role of regulatory T-cells in their control. Notably, the thymus-
committed naïve-Treg population was found to be maintained in these adults by peripheral
homeostatic mechanisms, despite the lack of thymic output since early in infancy[15]. Naïve-
Tregs are considered to play a major role in the control of self-reactivity due to their enrich-
ment in self-reactive T-cell receptors[14].
Nevertheless, beyond this well acknowledged role of the Treg compartment in the con-
tainment of autoimmunity, other factors may control the emergence of autoimmunity [32].
Autoimmune diseases are reported in 7.6–9.4% in the general population[33], and the relative
contribution of constriction of the TCR repertoire is not well established [34], However, al-
though we recognize the need for studies including a larger number of individuals, we believe
that our findings significantly contribute to the field because we gathered a homogenous
population of young adults without thymic activity and took advantage of highly sensitive
Fig 3. IgM autoantibody profile. Heatmaps of serum IgM autoantibody reactivity in adults thymectomized
early in infancy (T) and controls (C), clustered by autoantigen and subject group. Reactivity intensities were
normalized and log2-transformed; and 122 IgM autoantibodies meeting minimal net fluorescence intensity
requirements are presented. Key color bar corresponds to quantified reactivity.
https://doi.org/10.1371/journal.pone.0180385.g003
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methodologies to reveal possible subclinical increases in autoreactivity in thymectomized
individuals.
Cohorts of adults submitted to thymectomy in infancy are expanding due to generalization
of the access to early corrective/palliative cardiac surgery, though the eldest individuals are still
in the fourth decade of life[1]. Therefore, both extended follow-up and larger cohorts will be
very important. Although we found no significant differences between cohorts, the thymecto-
mized group featured a trend to increased subclinical IgG autoreactivity against antigens with
relevant clinical associations. Patients´ follow-up will ultimately reveal whether the relatively
preserved Treg compartment will be able to limit overt progression towards autoimmune dis-
ease[29].
There are several previous studies addressing whether thymectomy performed early in life
is associated with the subsequent development of autoimmunity and allergy[3–8]. An increase
in the frequency of allergic manifestations was suggested based on questionnaires, although
no data on skin testes or specific IgE quantifications were provided[3, 4, 7]. Conversely, there
are no reports of autoimmune diseases based on clinical questionnaires [4–8]. Three of these
studies also evaluated autoantibodies [3] [5, 7]. Two were performed in children without strati-
fication according to thymic activity and found no increase in antibody titers against thyro-
globulin, parietal cells and pancreatic islet cells[7], or rheumatoid factor and ANA [5]. The
third included both children and adults grouped according to sjTREC levels and evidence of
residual thymic tissue in subsequent surgeries or radiologic imaging, and reported an increase
in the levels of anti-dsDNA without association with clinical symptoms or presence or absence
of residual thymic tissue, although these individuals featured reduced sjTRECs[3].
Our study applied strict criteria to exclude individuals with remaining thymic activity due
to incomplete thymus removal and/or ectopic thymus. Of note, cardiothoracic surgeries have
revealed a high frequency of ectopic thymic tissue [35]. Moreover, we focused on adults with
more than 18 years of follow-up post complete thymectomy, aiming a population homogeneity
that we believe minimizes the limitation imposed by the relatively small numbers. Addition-
ally, we used an innovative evaluation of subclinical autoreactivity/IgE-sensitizations in order
to reveal possible immune dysregulation in individuals lacking thymic activity. It has been
demonstrated autoantigen arrays correlate very well with data generated by ELISA with much
higher sensitivity[29].
Individuals submitted to thymectomy in infancy have been considered a privileged model
to address the contribution of the thymus and of peripheral mechanisms to control autoimmu-
nity and allergy. Our data are consistent with the possibility that in the absence of thymic activ-
ity, peripheral tolerance limits the emergence of autoimmunity possibly through relative Treg
preservation. These findings have implications for other clinical settings with impaired thymic
activity. Particularly, they may steer the development of new strategies targeting peripheral
immunoregulatory systems and thymus regeneration to control autoimmunity in the context
of ageing or disease-associated thymus involution.
Supporting information
S1 Table. Normalized Log 2 transformed values of serum IgG autoreactivity intensity.
Samples and antigens are in the same hierarchical order as shown in the corresponding
Fig 4. IgE autoantibody profiles. Heatmaps of serum IgE autoantibody reactivities in adults thymectomized
early in infancy (T) and controls (C) clustered by autoantigen and subject group. Reactivity intensities were
normalized and log2-transformed, and 100 IgE autoantibodies meeting minimal net fluorescence intensity
requirements are presented. Key color bars correspond to quantified reactivity.
https://doi.org/10.1371/journal.pone.0180385.g004
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heatmap figure.
(XLS)
S2 Table. Normalized Log 2 transformed values of serum IgA autoreactivity intensity.
Samples and antigens are in the same hierarchical order as shown in the corresponding heat-
map figure.
(XLS)
S3 Table. Normalized Log 2 transformed values of serum IgM autoreactivity intensity.
Samples and antigens are in the same hierarchical order as shown in the corresponding heat-
map figure.
(XLS)
S4 Table. Normalized Log 2 transformed values of serum IgE autoreactivity intensity. Sam-
ples and antigens are in the same hierarchical order as shown in the corresponding heatmap
figure.
(XLS)
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